ALS Therapy Development Foundation
The mission of the ALS Therapy Development Institute (ALS TDI) is to develop effective therapeutics that stop ALS as soon as possible. Focused on meeting this urgent unmet medical need, ALS TDI executes a robust discovery program, as well as a multi-pronged approach to validate potential therapeutics; including small molecules, protein biologics, gene therapies and cell-based constructs. The Institute's unique, industrial-scale platform allows for the development and testing of dozens of potential therapeutics each year. Built by and for patients, the Institute is the world's largest ALS research center and the only nonprofit biotechnology company with more than 30 professional scientists focused on a single disease indication. In addition, the Cambridge, Massachusetts based research Institute collaborates with leaders in both academia and industry.
Contact Details
Office Address
ALS Therapy Development Foundation
215 First St
Cambridge, MA , USA 02142
Phone: (617) 441-7200
Fax: (617) 441-7299
Executives
President
Sean Scott
CFO
Maureen A. Lister
.webp)
.webp)
.webp)
.webp)
.webp)
